Overview

U.S. Topical Pain Relief Market Introduction

U.S. Topical Pain Relief Market is estimated to value over USD 3.4 billion by 2027 end and register a CAGR of over 5% during the forecast period 2020 to 2027.

Topical pain relievers are medications that are directly applied to the skin’s epidermal layer at the area of inflammation or pain. Development of new drug administration routes has emphasized on providing patients with ease of medical treatment without making any compromises on the medication efficiency. Topical pain relievers are designated for pain relief and use the skin as the medium for exerting leading action at targeted sites and in the central nervous system and for administrating drugs. Topical pain relievers are capable of releasing targeted medication that gradually gets into the bloodstream keeping constant blood levels. This enables a patient to continue with chronic disease-related medications for long periods. 

 

Topical pain relievers are a good alternative for those unable to take oral medications. Topical pain relievers include the drug administrations of capsaicin, tricyclic antidepressants, ketamine, opioids, clonidine, NSAIDs, local anaesthetics and cannabinoids. These medications are available in the form of foams, roll-ons. creams, gels, sprays, patches and sticks.

 

Basis the distribution channel, the U.S topical pain relief market is fragmented into e-commerce, pharmacies and drug stores and retail and grocery stores. Pharmacies and drug stores accounted for the largest U.S topical pain relief market share due to wide availability and higher presence of drugs. On the contrary, the e-commerce segment is predicted to exhibit significant U.S. topical pain relief market growth over the forecast period due to higher literacy digital-wise amongst the population. Furthermore, these pharmacies offer many advantages like more convenience, easy access to patient reviews, fewer expenses and price comparisons, which drive the segment’s market growth.

 

The key players of this market include Johnson & Johnson, Novartis AG, GlaxoSmithKline Plc., Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Topical BioMedics, Inc., AdvaCare Pharma, Sun Pharmaceutical Industries Ltd., and Nestle S.A.

 

U.S Topical Pain Relief Market Segmentation:

By Therapeutic Class

  • Non-opioids 
    • Non-steroidal Anti-Inflammatory Drugs (NSAIDS)
    • Methyl Salicylate
    • Capsaicin
    • Lidocaine
    • Other Non-opioids
  • Opioids 
    • Buprenorphine
    • Fentanyl

By Type

  • Prescription Pain Relief
  • Over-the-counter (OTC) Pain Relief

By Formulation

  • Cream
  • Gel
  • Spray
  • Patch
  • Others

By Distribution Channel

  • Pharmacies & Drug Stores
  • E-commerce
  • Retail & Grocery Stores

 

FutureWise Key Takeaways:

• Growth prospects

• SWOT analysis 

• Key trends 

• Key data-points affecting market growth 

 

Objectives of the Study:

  • To provide with an exhaustive analysis on the U.S topical pain relief market by therapeutic class, by type, by formulation and by distribution channel 
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market 
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics